Microbial and Phage Cultivation Core
Microbial and Phage Cultivation Core
批准号:
10583460
负责人:
ROBERT A BRITTON
金额:
$38.24万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-03-01 至 2026-02-28
关键词:
Animal Disease ModelsAnti-Bacterial AgentsAntibiotic ResistanceBacteriaBacterial Antibiotic ResistanceBacteriophagesClostridium difficileCollectionCommunitiesComplexDedicationsDiseaseESKAPE pathogensEtiologyEvolutionFacultyFoundationsGenerationsGenesGenomeGenomicsGoalsHealthHomeostasisHumanHuman MicrobiomeHuman ResourcesHuman bodyIndividualInfrastructureIntestinesInvestmentsLaboratoriesLibrariesLyticMedicineMetagenomicsMicrobeMissionMucous MembraneNatureNoseOrganoidsPathogenicityProductionReagentResearchResourcesRoleScientistSequence AnalysisServicesSiteSurfaceTherapeuticVaginaViralatmospheric conditionscollegecombatcostdata integrationdeep sequencinggene functionhuman modelinnovationmetagenomemetagenomic sequencingmicrobialmicrobial communitymicrobial genomemicrobiomemicrobiome alterationmicrobiome researchnovelpathogenpathogenic bacteriaresiliencetooltranslational study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The overall goal of the BCM-CARBIRU is to explore non-antibiotic therapeutic approaches to
combating antibiotic resistant bacterial pathogens that are deemed urgent and serious threats. To
meet this goal, the establishment of the Microbial and Phage Cultivation (MPC) core will provide to
the projects the ability to cultivate bacteria and phage in multiple formats and under different
atmospheric conditions. The core will also provide sequencing support of newly identified bacteria
and phage that emerge from each of the three projects. The MPC organized around three primary
objectives.
Objective 1. Cultivation of complex microbial communities and individual microbes.
Objective 2. Isolation and optimization of bacteriophage for AMR pathogens.
Objective 3. Sequencing of individual microbes, phage and complex microbial communities.
Centralization of these objectives into the MPC core will reduce costs by allowing all of the projects
access to the infrastructure (such as anaerobic and microoxic chambers), bulk purchasing of
reagents, and the reduction in labor costs by having dedicated technicians to assist in generation of
bacteria and phage. The MPC will facilitate the transfer of expertise in microbial and phage
cultivation from the core to trainees from all three projects. Finally, a centralized resource for
sequencing of bacteria and phage will allow more coordination between the projects in regard to
genomic analysis and data integration. The MPC will be an essential part of the BCM-CARBIRU that,
along with the Organoid Cultivation Core, will help achieve the overall goals proposed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multi-method investigation and characterization of the ocular microbiome
-
批准号:10660691
-
项目类别:
-
资助金额:$66.33万
-
财政年份:2023
-
负责人:ROBERT A BRITTON
-
依托单位:
Engineered probiotic for the treatment of autoimmune diseases
-
批准号:10561101
-
项目类别:
-
资助金额:$68.23万
-
财政年份:2023
-
负责人:ROBERT A BRITTON
-
依托单位:
Defined microbial communities to prevent and eradicate infection by AMR pathogens
-
批准号:10357969
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2021
-
负责人:ROBERT A BRITTON
-
依托单位:
Admin Core - Britton
-
批准号:10583458
-
项目类别:
-
资助金额:$24.02万
-
财政年份:2021
-
负责人:ROBERT A BRITTON
-
依托单位:
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
-
批准号:10357964
-
项目类别:
-
资助金额:$240.27万
-
财政年份:2021
-
负责人:ROBERT A BRITTON
-
依托单位:
Microbial and Phage Cultivation Core
-
批准号:10357966
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2021
-
负责人:ROBERT A BRITTON
-
依托单位:
Admin Core - Britton
-
批准号:10357965
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2021
-
负责人:ROBERT A BRITTON
-
依托单位:
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
-
批准号:10583457
-
项目类别:
-
资助金额:$253.78万
-
财政年份:2021
-
负责人:ROBERT A BRITTON
-
依托单位:
Defined microbial communities to prevent and eradicate infection by AMR pathogens
-
批准号:10583468
-
项目类别:
-
资助金额:$56.87万
-
财政年份:2021
-
负责人:ROBERT A BRITTON
-
依托单位:
Diet driven evolution of epidemic ribotypes of Clostridium difficile
-
批准号:10053311
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2017
-
负责人:ROBERT A BRITTON
-
依托单位:
Diet driven evolution of epidemic ribotypes of Clostridium difficile
-
批准号:10291417
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2017
-
负责人:ROBERT A BRITTON
-
依托单位:
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection
-
批准号:9108593
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2016
-
负责人:ROBERT A BRITTON
-
依托单位:
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection
-
批准号:9333177
-
项目类别:
-
资助金额:$149.47万
-
财政年份:2016
-
负责人:ROBERT A BRITTON
-
依托单位:
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection
-
批准号:9764246
-
项目类别:
-
资助金额:$148.2万
-
财政年份:2016
-
负责人:ROBERT A BRITTON
-
依托单位:
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection
-
批准号:9981615
-
项目类别:
-
资助金额:$148.69万
-
财政年份:2016
-
负责人:ROBERT A BRITTON
-
依托单位:
GTPase control of large ribosome subunit biogenesis
-
批准号:9016564
-
项目类别:
-
资助金额:$37.96万
-
财政年份:2015
-
负责人:ROBERT A BRITTON
-
依托单位:
GTPase control of large ribosome subunit biogenesis
-
批准号:8674071
-
项目类别:
-
资助金额:$41.04万
-
财政年份:2015
-
负责人:ROBERT A BRITTON
-
依托单位:
GTPase control of large ribosome subunit biogenesis
-
批准号:9217658
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2015
-
负责人:ROBERT A BRITTON
-
依托单位:
GTPase control of large ribosome subunit biogenesis
-
批准号:9438546
-
项目类别:
-
资助金额:$37.52万
-
财政年份:2015
-
负责人:ROBERT A BRITTON
-
依托单位:
Defined microbial communities for the treatment of recurrent C. difficile infection
-
批准号:9019907
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2015
-
负责人:ROBERT A BRITTON
-
依托单位:
海外基金